Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-022-02025-9, published online 5 November 2022
The original version of this article contained an error in an affiliation. As per Italian regulation, the two affiliations for Dr. Curigliano (Istituto Europeo di Oncologia, IRCCS and University of Milan, Milano, Italy) must be separated out for proper accreditation within their systems. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Curigliano, G., Shapiro, G.I., Kristeleit, R.S. et al. Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer. Br J Cancer 128, 400 (2023). https://doi.org/10.1038/s41416-023-02161-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-023-02161-w
